Logo featuring "BIOVECTRA" in purple text with a blue and yellow abstract design, and the phrase "A part of Agilent" below.
Facebook Linkedin

WEBINAR

Unleashing the Potential of ADCs with High-Quality Bioreagents

Learn More About our Bioreagents

Harnessing the potential of ADCs requires the highest standards in manufacturing. That’s why we proudly present our cGMP-certified Tris (2-carboxyethyl) phosphine, hydrochloride (TCEP) and Dehydroascorbic Acid dimer (DHAA) – the winning combination for superior ADC production.

Our cGMP-grade DHAA and TCEP are the perfect redox partners for ADC manufacturing. They not only meet the rigorous requirements set forth by regulatory authorities but are manufactured with the highest levels of purity and characterization.

Elevate your ADC production to new heights of efficiency, stability, and compliance – minimizing risks associated with regulatory approvals and ensuring patient safety with our cGMP materials.

© BIOVECTRA 2024. All rights reserved

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications